Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
2018
Background/Aims
We investigated the efficacy and toxicity of a weekly schedule of docetaxel and cisplatin as a first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
45
References
0
Citations
NaN
KQI